Inactive Instrument

Insiders Sorrento Therapeutics Inc Other OTC

Equities

US83587F1030

End-of-day quote Other OTC Other stock markets
- ^USD	-

Mar. 15	Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs	MT
Mar. 12	News Highlights : Top Company News of the Day - Tuesday at 5 AM ET	DJ

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sorrento Therapeutics, Inc. Announces Termination of the Employment of Elizabeth Czerepak as Its Executive Vice President	Nov. 07	CI
Sorrento Therapeutics, Inc. Announces Resignation of Tammy Reilly from the Board of Directors	23-10-27	CI
Sorrento Therapeutics, Inc. Appoints Former Roche Executive Tammy Reilly to the Board of Directors	22-05-18	CI
Sorrento Therapeutics Announces the Appointment of Laura Hamill to Its Board of Directors	22-04-12	CI
Sorrento Therapeutics, Inc. Announces Demise of Najjam Asghar, Senior Vice President	22-01-07	CI
Sorrento Therapeutics, Inc. Approves the Appointment of Elizabeth A. Czerepak as Director	21-11-18	CI
Insider Sell: Sorrento Therapeutics	21-09-28	MT
Sorrento Therapeutics, Inc. Announces Executive Changes	20-08-18	CI
Sorrento Appoints Robin Smith as New Member of the Board of Directors	19-12-16	CI
Sorrento Therapeutics, Inc. Appoints Edgar Lee to Its Board of Directors	19-12-09	CI
Sorrento Therapeutics, Inc. Announces Management Changes	18-03-19	CI
Sorrento Therapeutics, Inc. Announces Board Appointments	17-10-02	CI
Jeffrey Su Resigns as Chief Operating Officer of Sorrento Therapeutics, Inc., Effective June 30, 2017	17-06-29	CI
Sorrento Therapeutics, Inc. Appoints Miranda Toledano as Executive Vice President of Corporate Development, and President of LA Cell	16-09-13	CI
Sorrento Therapeutics, Inc. Appoints Jerome Zeldis as Chief Medical Officer and President of Clinical Development	16-08-15	CI
Sorrento Therapeutics, Inc. Appoints Yue Alexander Wu, Ph.D to Board of Directors	16-08-01	CI
Sorrento Therapeutics, Inc. Appoints Kevin M. Herde as Executive Vice President & Chief Financial Officer	16-04-05	CI
ImmuneOncia Appoints Su Youn Nam as CEO	16-03-02	CI
Sorrento Therapeutics, Inc. Appoints Jeffrey Su as Executive Vice President and Chief Operating Officer	15-10-19	CI
George Uy Leaves Sorrento Therapeutics, Inc. as Executive Vice President and Chief Commercial Officer	15-07-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Sorrento Therapeutics Inc Other OTC

Equities

US83587F1030

Insiders

Filters